The US Food and Drug Administration (FDA) is reminding healthcare providers about the risk of major complications if cardiac perforation occurs during leadless pacemaker implantation. Cardiac ...

Cherian*, an octogenarian, was a post by-pass surgery patient, who also underwent a stent implantation. He later developed a stent re-block which was opened again with a new technology called drug ...

The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...

With more self-contained models potentially on their way to patients, the FDA is taking steps to remind healthcare providers of certain risks posed by leadless pacemakers, including the possibility of ...

Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...

Pacemakers, relied upon by many patients with irregular heart rhythms, are not built for children. Scrambling up trees, hanging from monkey bars, and even the simple act of growing make the device ...

A novel leadless pacemaker designed for left bundle branch area pacing conferred successful pacing parameters at 1 month, but ...

Background: Patients over the age of 75 represent more than half the recipients of permanent pacemakers. It is not known if they have a different risk of complications than younger patients. Methods: ...

Only those patients who were fitted with a CRT device which is different and more complex than a standard pacemaker between ...

Approximately 48,000 pacemakers distributed between November 2011 and August 2020 have been recalled by Boston Scientific this summer, after the company became aware of a battery issue that could ...